Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Beyond 6 months of chronic undereating: Menstrual irregularities or loss
Improved accessibility of high-quality drugs to benefit patients As a national Class 1 new drug, Fulaimei was approved for marketing in China in May 2019, and was included in the National Reimbursement Drug List at the end of December 2020
Lifestyle modifications implemented during treatment can help preserve some benefit if medication discontinuation becomes necessary
Research use only means AOD+CJC+Ipamorelin Blend is positioned as a laboratory research material rather than a consumer, clinical, veterinary, or diagnostic product
US$ 25.57
US$ 21.48
![Mechanism of action of GLP-1 [25]](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png)
US$ 25.08
US$ 19.99
US$ 27.37
US$ 28.74
US$ 25.17
US$ 24.65
US$ 20.52
